Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Communication Services | 10.53% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
IBEX
IBEX
$485M
| $3.6M | ﹤0.01% |
88,900
-21,200
| -19% | -$674K |
|
1677
Heron Therapeutics
HRTX
$96.8M
| $3.6M | ﹤0.01% |
2,854,999
+165,660
| +6% | +$263K |
|
1678
Allogene Therapeutics
ALLO
$656M
| $3.59M | ﹤0.01% |
2,893,812
+1,223,800
| +73% | +$1.46M |
|
1679
Schwab 1000 Index ETF
SCHK
$5.9B
| $3.58M | ﹤0.01% |
111,600
+72,200
| +183% | +$2.23M |
|
1680
Provident Financial
PROV
$112M
| $3.58M | ﹤0.01% |
227,147
-3,300
| -1% | -$51.2K |
|
1681
Cleveland-Cliffs
CLF
$7.02B
| $3.57M | ﹤0.01% |
+292,659
| New | +$3.08M |
|
1682
Johnson Outdoors
JOUT
$506M
| $3.57M | ﹤0.01% |
88,300
-12,200
| -12% | -$455K |
|
1683
Atea Pharmaceuticals
AVIR
$376M
| $3.56M | ﹤0.01% |
1,227,900
-6,200
| -0.5% | -$21.2K |
|
1684
Diana Shipping
DSX
$311M
| $3.55M | ﹤0.01% |
2,115,413
+18,600
| +0.9% | +$30.8K |
|
1685
CSP Inc
CSPI
$84M
| $3.54M | ﹤0.01% |
306,526
+3,000
| +1% | +$35.2K |
|
1686
International General Insurance
IGIC
$1.19B
| $3.54M | ﹤0.01% |
152,500
+17,900
| +13% | +$429K |
|
1687
Vanguard Total Bond Market
BND
$158B
| $3.53M | ﹤0.01% |
+47,500
| New | +$3.5M |
|
1688
Latham Group
SWIM
$669M
| $3.53M | ﹤0.01% |
464,000
-113,100
| -20% | -$832K |
|
|
DCBO
1689
Docebo
DCBO
$523M
| $3.53M | ﹤0.01% |
129,133
+16,502
| +15% | +$499K |
|
1690
Northeast Community Bancorp
NECB
$372M
| $3.53M | ﹤0.01% |
171,400
+2,600
| +2% | +$57.3K |
|
1691
Bar Harbor Bankshares
BHB
$682M
| $3.52M | ﹤0.01% |
115,688
-7,796
| -6% | -$244K |
|
1692
Ascent Industries
ACNT
$139M
| $3.52M | ﹤0.01% |
273,300
+5,500
| +2% | +$69.3K |
|
1693
Zentalis Pharmaceuticals
ZNTL
$347M
| $3.51M | ﹤0.01% |
2,325,355
+795,802
| +52% | +$1.19M |
|
|
NAKA
1694
Nakamoto Inc
NAKA
$88.2M
| $3.5M | ﹤0.01% |
+81,723
| New | +$25.9M |
|
1695
Gran Tierra Energy
GTE
$242M
| $3.48M | ﹤0.01% |
799,880
-29,700
| -4% | -$126K |
|
1696
Camping World
CWH
$676M
| $3.48M | ﹤0.01% |
+220,300
| New | +$3.77M |
|
1697
Dorian LPG
LPG
$1.86B
| $3.48M | ﹤0.01% |
116,700
-44,272
| -28% | -$1.33M |
|
1698
Victory Capital Holdings
VCTR
$6.42B
| $3.47M | ﹤0.01% |
+53,600
| New | +$3.68M |
|
1699
YieldMax Ultra Option Income Strategy ETF
ULTY
$780M
| $3.47M | ﹤0.01% |
63,420
-68,713
| -52% | -$4.07M |
|
1700
Organogenesis Holdings
ORGO
$305M
| $3.47M | ﹤0.01% |
821,500
+17,600
| +2% | +$81.8K |
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 516 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.